AI Medical Imaging Software Development: 2026 Roadmap

A radiologist reviews 200 images a day. At that volume, fatigue is inevitable, and missed findings are a real clinical risk.

AI medical imaging software changes that equation. It does not replace the radiologist. It works alongside them, flagging anomalies, prioritising urgent cases, and reducing the cognitive load that produces errors at hour seven of a twelve-hour shift.

In 2026, AI medical imaging software development has moved out of research labs and into live clinical environments. Hospitals use it to detect early-stage cancers. Emergency departments use it to prioritise stroke patients. Pathology labs use it to analyse slides at a scale no human team could match.

If you are a healthcare startup, a health system, or a clinic exploring what it actually takes to build one of these products and get it into clinical use, this guide covers the full path: clinical problem definition, regulatory strategy, training data, model development, clinical integration, reimbursement, and the operational monitoring that keeps it working after launch.

What Is AI Medical Imaging Software?

AI medical imaging software is a clinical tool that uses machine learning and deep learning to analyse medical images and assist clinicians in detecting, diagnosing, and monitoring conditions, typically by flagging suspected findings, quantifying structures, and prioritising studies for review.

Medical images include X-rays, CT scans, MRIs, ultrasounds, mammograms, and digitised pathology slides. Traditionally, these are reviewed entirely by radiologists, pathologists, or other specialists, a time-intensive process that depends heavily on individual expertise and sustained attention.

AI medical imaging software adds a layer of automated analysis that can identify patterns a human reviewer might miss, prioritise studies needing urgent attention, and deliver consistent output at a speed and scale no human team can match.

The key distinction, and the one that determines both your regulatory pathway and your clinical adoption curve, is that the best platforms augment clinical judgement rather than replace it. The AI surfaces what it finds. The clinician makes the call.

Why AI Medical Imaging Development
Is Growing So Fast in 2026

AI medical imaging is growing because three forces converged: a genuine radiologist supply shortage against rising imaging volume, a regulatory pathway that has become predictable rather than experimental, and clinical validation data from real deployments rather than research settings.

The clinical need is urgent. Radiology departments across the United States are understaffed. The demand for imaging studies is growing faster than the supply of radiologists. AI that can triage studies, flag critical findings, and reduce the time from scan to diagnosis addresses a real and pressing clinical problem.

The regulatory pathway has matured. The FDA has cleared more than 500 AI-enabled medical devices, a significant portion of them in medical imaging. The regulatory framework for AI imaging tools is more predictable than it was three years ago, which has accelerated investment and development.

The technology has proven itself in clinical settings. Early AI imaging tools were evaluated in controlled research environments. The tools generating adoption in 2026 have been validated in real clinical environments with real patients, and the outcomes data support their use.

The global AI in medical imaging market is projected to exceed $20 billion by 2030. For healthcare startups and clinics considering this space, the window for building genuinely differentiated products is now.

Types of AI Medical Imaging Software Development

The six main categories of AI medical imaging software are radiology detection and triage, computational pathology, ophthalmic retinal analysis, cardiac imaging analysis, dermatological lesion analysis, and radiation oncology treatment planning. Each carries a different regulatory burden and a different clinical integration path.

1. Radiology AI: detection and triage

Tools that analyse X-rays, CT, and MRI to detect abnormalities such as nodules, fractures, haemorrhages, and tumours, and to prioritise studies for radiologist review. This is the largest and most mature category, and the one with the deepest pool of 510(k) predicates.

2. Pathology AI: digital slide analysis

Tools that analyse digitised pathology slides to identify cancerous cells, grade tumours, and quantify biomarkers. Computational pathology is among the fastest-growing areas, driven by wider availability of whole-slide imaging. Note the engineering implication: a single whole-slide image can run to several gigabytes, which changes your storage, tiling, and inference architecture entirely.

3. Ophthalmology AI: retinal imaging analysis

Tools that analyse retinal images to detect diabetic retinopathy, glaucoma, and age-related macular degeneration. This category contains the clearest precedent for autonomous AI, where the software produces a diagnostic result without a specialist reviewing the image.

4. Cardiology AI: cardiac imaging analysis

Tools that analyse echocardiograms, cardiac MRI, and coronary CT angiography to assess cardiac function, detect structural abnormalities, and identify coronary artery disease. This category has the strongest current reimbursement position, with several dedicated CPT codes.

5. Dermatology AI: skin lesion analysis

Tools that analyse dermoscopy images and clinical photographs to separate benign from malignant lesions, increasingly deployed in primary care to extend specialist-level screening. Expect elevated regulatory scrutiny here, particularly around performance across skin tones.

6. Radiation oncology AI: treatment planning

Tools that assist radiation oncologists in delineating target volumes and organs at risk in CT and MRI, reducing planning time and improving consistency between practitioners.

What features does every AI medical imaging platform need?

Every AI medical imaging platform needs DICOM compatibility, a production inference engine, PACS and RIS worklist integration, confidence scoring and explainability, critical finding alert routing, comprehensive audit logging, EHR integration via HL7 FHIR, and a performance monitoring dashboard.

DICOM compatibility. DICOM (Digital Imaging and Communications in Medicine) is the universal standard for medical imaging data. Any platform must ingest, process, and display DICOM. This is not a feature; it is the baseline requirement for existing in clinical imaging infrastructure at all.

AI inference engine. The system that applies trained models to new studies and produces outputs. It needs to be fast enough for clinical workflow, accurate enough to earn trust, and explainable enough that clinicians understand the basis for its output. For triage products, latency is a clinical requirement, not a performance nicety.

Clinical worklist integration. Findings must reach radiologists through the systems they already use: PACS (Picture Archiving and Communication Systems) and RIS (Radiology Information Systems). A tool that requires a separate interface will not be adopted consistently.

Confidence scoring and explainability. Clinicians need to know what the model found, how confident it is, and why. Confidence scores, heatmaps highlighting the image regions driving the finding, and honest uncertainty quantification are prerequisites for clinical trust.

Alert and prioritisation logic. When the AI identifies a critical finding such as a large pulmonary embolism or an intracranial haemorrhage, the right clinician needs to know immediately. Alert routing that prioritises critical findings and delivers them through the right channel is a clinical safety requirement.

Audit trail and logging. Every finding, every clinician interaction, and every case outcome logged. This supports HIPAA compliance, enables quality analysis, and produces the documentation needed for regulatory reporting and post-market surveillance.

EHR integration. Findings need to flow into the patient record so the full clinical team can see them. Clean integration using HL7 FHIR is essential for both workflow and compliant data exchange. Our EHR and EMR integration practice has built these integrations for clinical imaging workflows, including the authentication patterns and edge cases that only surface in production.

Performance monitoring dashboard. Clinical and operational performance made visible: sensitivity and specificity in deployment, time-to-read improvement, case volume by finding type, and alert response times. Clear healthcare UI/UX design makes this data actionable for clinical leadership rather than decorative.

How do you build AI medical imaging software, step by step?

You build AI medical imaging software in ten steps: define the clinical indication, determine the regulatory pathway, assemble and annotate the training dataset, design and train the model, validate against clinical standards, build the clinical integration layer, design the clinician interface, implement HIPAA-compliant infrastructure, run a structured clinical pilot, then monitor and maintain model performance in production.

Step 1: Define the Clinical Problem and Target Indication

AI medical imaging software development begins with a specific clinical problem, not a general ambition to "improve radiology with AI." The more specific the indication, the clearer the regulatory pathway, the more focused the training data requirements, and the more targeted the clinical validation.

Define exactly what the AI will analyze, what it will detect or measure, what clinical decision it will support, and what the clinical workflow looks like before and after the AI is introduced. This specificity drives every technical decision that follows.

Step 2: Determine the Regulatory Pathway

Before any development begins, determine whether your AI imaging tool will be regulated by the FDA as a Software as a Medical Device (SaMD). Most AI tools that make diagnostic or clinical claims, detect findings, measure structures, or assess risk are regulated. Understanding your regulatory classification early is essential.

If FDA clearance is required, determine whether the 510(k) pathway, De Novo classification, or PMA process is appropriate for your indication. Engage a regulatory consultant at this stage, not after development is complete.

Our HIPAA-compliant software development practice navigates these regulatory questions before development begins, which is the only approach that avoids expensive rebuilds when regulatory requirements surface late.

Step 3: Assemble and Curate the Training Dataset

The performance of an AI medical imaging model is entirely determined by the quality of the data it was trained on. This means assembling a large, diverse, clinically annotated dataset of medical images that represents the patient population the AI will serve.

Clinical annotation, having radiologists, pathologists, or specialists label the findings in the training images, is the most time-consuming and expensive part of dataset preparation. The quality of these annotations directly determines the quality of the AI model.

Data diversity matters critically. A model trained on images from one institution, one scanner manufacturer, or one patient demographic will perform poorly when deployed in different clinical environments. Building a training dataset that reflects the diversity of real clinical practice is a clinical safety requirement, not just a technical nicety.

Step 4: Design and Train the AI Model

Choose the model architecture appropriate for your specific imaging task. Deep learning approaches, specifically convolutional neural networks (CNNs) for image classification and detection, and transformer-based architectures for more complex analysis tasks, are the standard in 2026.

Key model development decisions include the choice between building a model from scratch versus fine-tuning a pre-trained foundation model, the approach to handling class imbalance (rare findings are typically underrepresented in training data), and the method for generating explainability outputs, such as gradient-weighted class activation maps (Grad-CAM) and similar techniques, which are commonly used to produce the heatmaps that show clinicians where in the image the AI is focusing.

Our AI and ML solutions team has experience building and validating medical imaging models for clinical environments, including the techniques for handling the data imbalance, image artifact challenges, and scanner variability that real clinical imaging datasets present.

Step 5: Validate Model Performance Against Clinical Standards

Training a model that performs well on the training dataset is necessary but not sufficient. Clinical validation requires demonstrating that the model performs reliably on data it has never seen, drawn from the same clinical population it will serve in deployment.

Validation metrics for medical imaging AI typically include sensitivity (the rate at which the model correctly identifies true positives), specificity (the rate at which it correctly identifies true negatives), AUC-ROC (the overall discrimination performance across all decision thresholds), and positive and negative predictive values.

For FDA-regulated devices, clinical validation needs to be conducted under a formal study protocol with appropriate statistical powering and independent review. The performance claims made in the FDA submission must be supported by validation data collected in accordance with this protocol.

Step 6: Build the Clinical Integration Layer

A model that performs well in isolation is not a clinical product. The clinical integration layer, the software that connects the AI model to the clinical environment, is where most AI medical imaging projects encounter their most significant engineering challenges.

This layer includes DICOM ingestion and pre-processing, integration with the PACS and RIS, EHR integration for finding documentation, alert routing logic, the clinician-facing interface for reviewing AI findings, and the audit logging required for HIPAA compliance and regulatory reporting.

Our healthcare software development team builds this integration layer with the clinical workflow in mind, designing for the systems radiologists actually use and the time constraints they actually face.

Step 7: Design the Clinician Interface

The interface through which clinicians interact with AI findings is where clinical adoption is won or lost. Radiologists who find the AI findings difficult to access, hard to interpret, or disruptive to their reading workflow will not use the tool consistently.

Design principles for AI imaging interfaces include surface-level visibility of critical findings, clear confidence scoring, intuitive heatmap visualization, one-click access to the full image context, and seamless return to the reading workflow after reviewing an AI finding.

This is specialized clinical UX work. Our healthcare UI/UX design team designs and tests clinical interfaces with real radiologists and clinicians from the target specialty because assumptions about clinical interface preferences are almost always wrong until tested with real users.

Step 8: Implement HIPAA-Compliant Infrastructure

Medical imaging data is protected health information. Every system that handles it must comply with HIPAA. For AI medical imaging software, this means encrypted DICOM data transmission and storage, role-based access controls, comprehensive audit logging, and Business Associate Agreements with every third-party service in the infrastructure stack.

Cloud infrastructure for medical imaging also needs to address the specific performance requirements of imaging workloads, large file sizes, high-throughput processing, and the low-latency inference that clinical workflows require.

Step 9: Deploy With a Structured Clinical Pilot

Before broad deployment, run a structured clinical pilot for a defined period of real clinical use with a small group of radiologists or clinicians, agreed-upon success metrics, and a clear process for collecting feedback and measuring performance.

A good pilot generates the clinical evidence needed to support both regulatory submissions and commercial conversations, and identifies the integration issues and workflow gaps that internal testing cannot reliably surface.

Step 10: Monitor, Iterate, and Maintain Model Performance

AI medical imaging models require ongoing monitoring after deployment. Model performance can degrade as scanner technology changes, patient populations shift, or clinical protocols evolve, a phenomenon called dataset drift. Building monitoring infrastructure that detects performance changes and triggers model update cycles is an ongoing operational requirement.

Technology Stack for AI Medical Imaging Development

AI and Machine Learning Framework

PyTorch is the dominant framework for medical imaging AI research and development in 2026. Its dynamic computation graph makes it well-suited to the experimental development process that medical AI requires. TensorFlow and its serving infrastructure remain relevant for production deployment at scale.

For foundation model fine-tuning, MONAI Medical Open Network for AI is an open-source framework specifically designed for medical imaging AI that provides pre-built components for common imaging tasks and is built on PyTorch.

DICOM Processing

Pydicom for DICOM file parsing and manipulation. Orthanc or DCM4CHEE as open-source DICOM servers for storing and routing imaging studies. OHIF Viewer is an open-source web-based DICOM viewer for building clinical interfaces.

Backend and API

Python with FastAPI is the standard backend choice for medical imaging AI platforms. Python's machine learning ecosystem is unmatched, and FastAPI provides the performance and async capability needed for high-throughput imaging workloads.

Cloud Infrastructure

AWS with HIPAA-eligible services is the most common cloud choice for US-based medical imaging AI. Key services include Amazon S3 for DICOM storage, Amazon SageMaker for model training and deployment, and AWS HealthImaging for managed DICOM storage and retrieval. All services must be within the AWS HIPAA-eligible service catalog, and a Business Associate Agreement must be in place before patient imaging data is stored.

GPU compute is essential for both model training and inference. AWS P3 and P4 instance families provide the GPU resources needed for training large imaging models. For inference in clinical settings, optimized GPU instances or dedicated inference endpoints provide the sub-second response times that clinical workflows require.

EHR Integration

HL7 FHIR R4 is the current standard for clinical data exchange. DICOM Structured Reports can be used to encode AI findings in the DICOM format for PACS integration. FHIR ImagingStudy and DiagnosticReport resources are used for EHR integration.

Our API integration services team builds these integrations with the knowledge of interoperability standards that make them reliable in production clinical environments.

Security and Compliance

AWS KMS for encryption key management. AWS CloudTrail for comprehensive audit logging. AWS IAM for role-based access control. HIPAA-eligible AWS services only for all workloads that touch patient imaging data.

HIPAA Compliance and FDA Regulation for Medical Imaging AI

HIPAA Requirements for Medical Imaging AI

Medical images are protected health information. Every system that handles them, the AI model, the inference infrastructure, the DICOM storage, the EHR integration layer, and the clinical interface, must comply with the HIPAA Security Rule.

Specific requirements include AES-256 encryption at rest for all stored imaging data, TLS 1.2 or higher for all data in transit, role-based access controls restricting image access to authorized clinical users, comprehensive audit logs of all access to patient imaging data, and Business Associate Agreements with all third-party services.

FDA Regulation of AI Medical Imaging Software

Most AI medical imaging tools that make clinical claims, detect findings, measure structures, and assess risk, are regulated by the FDA as Software as a Medical Device. The regulatory pathway depends on the risk level of the clinical application.

510(k) clearance is the most common pathway for AI imaging tools, demonstrating that the device is substantially equivalent to an already-cleared device. De Novo classification is appropriate for novel low-to-moderate risk devices without a predicate. PMA (Premarket Approval) is required for high-risk devices.

The FDA's predetermined change control plan (PCCP) framework allows AI developers to plan for certain model updates addressing algorithm retraining as clinical data accumulates without requiring a new submission for every update.

Understanding your regulatory pathway before development begins is not cautious; it is the difference between building a product that can be legally deployed and one that requires extensive remediation before it can reach patients.

How Much Does AI Medical Imaging Software Development Cost?

The discovery and regulatory planning stage typically costs between $15,000 and $30,000 and takes about 4 to 8 weeks.

Dataset assembly and annotation is one of the most expensive and time-heavy steps, ranging from $50,000 to $200,000+ over 3 to 9 months.

Model development and validation usually costs between $80,000 and $250,000 and can take 4 to 12 months.

Building the clinical integration layer adds another $60,000 to $150,000, with a timeline of 3 to 6 months.

FDA regulatory submission support can cost anywhere from $30,000 to $100,000+, depending on complexity, and the timeline varies.

A full production-ready platform typically lands between $300,000 and $800,000+, taking around 12 to 24 months to complete.

The biggest cost drivers are dataset assembly and annotation, the most time-intensive phase in any medical imaging AI project, model validation requirements for the target indication, and the complexity of clinical integration with existing PACS and EHR systems.

How do you validate AI medical imaging for bias and health equity?

You validate for bias by measuring model performance separately across demographic subgroups, scanner manufacturers, acquisition protocols, and clinical sites, and by reporting those stratified results rather than a single aggregate performance figure.

An aggregate AUC hides the thing that matters most clinically. A model with strong overall performance can perform materially worse for a subgroup that was underrepresented in training, and in imaging that failure mode is well documented.

Practical requirements:

Stratify every performance metric by age, sex, race and ethnicity where available, body habitus, scanner manufacturer, acquisition protocol, and site.
Set minimum subgroup performance thresholds during validation design, not after you see the results.
Document the training population composition explicitly, including what is missing. Reviewers, health system buyers, and increasingly regulators all ask.
Monitor stratified performance after deployment, not just aggregate performance. Drift is rarely uniform across subgroups.
Publish a model card covering intended use, training population, validation results including subgroup breakdowns, known limitations, and failure modes. This is fast becoming a procurement expectation.

This is not only an ethical position. Under the ONC/ASTP HTI-1 Decision Support Intervention criterion, predictive decision support surfaced through certified health IT carries defined transparency obligations about how the model was developed and validated. Products that already document this cleanly clear procurement faster.

Common Mistakes to Avoid

The six most costly mistakes are training on data that does not represent deployment conditions, deferring regulatory strategy until after development, optimising for accuracy without explainability, underestimating clinical integration, neglecting post-deployment monitoring, and treating HIPAA as a late-stage concern.

1. Training on Data That Does Not Represent Deployment Conditions

A model trained on images from one institution's scanners will perform differently when deployed with different scanner brands, acquisition protocols, or patient populations. Build training datasets that reflect the diversity of clinical environments where the tool will be deployed.

2. Ignoring Regulatory Requirements Until After Development

The FDA regulatory pathway for an AI medical imaging tool affects how clinical validation studies must be designed, how the model's intended use must be defined, and what performance claims can be made. Discovering these requirements after development is complete is one of the most expensive mistakes in medical AI.

3. Building for Performance Without Building for Explainability

A model that achieves high sensitivity and specificity but cannot show clinicians where in the image it is focusing will not earn clinical trust. Explainability is not a nice-to-have feature it is a clinical adoption requirement.

4. Underestimating Clinical Integration Complexity

PACS integration, RIS integration, and EHR integration each require specific technical knowledge that is not obvious from documentation alone. Real integration experience, including the edge cases that only appear in production, is what makes the difference between an AI tool that fits into clinical workflows and one that clinicians have to work around.

5. Neglecting Post-Deployment Model Monitoring

Model performance changes after deployment as scanner technology, clinical protocols, and patient populations evolve. Building monitoring infrastructure that detects these changes before they affect clinical outcomes is an operational requirement, not an optional enhancement.

6. Treating HIPAA as a Late-Stage Concern

HIPAA compliance for medical imaging AI affects data architecture, infrastructure selection, third-party service contracts, and the audit logging built into the clinical integration layer. Retrofitting compliance into a system that was not designed for it is one of the most expensive and disruptive engineering projects a healthcare startup can undertake.

AI Medical Imaging Software Development Checklist

Clinical and Regulatory Foundation

Specific clinical indication defined with an intended use statement
Regulatory classification determined 510(k), De Novo, or PMA
Regulatory consultant engaged before development begins
Predetermined change control plan drafted for model updates

Dataset and Model Development

Training dataset assembled from diverse clinical environments
Clinical annotation performed by qualified specialists
Model architecture selected and justified for the indication
Explainability outputs included heatmaps and confidence scores
Validation study protocol designed and approved

Clinical Integration

DICOM ingestion and processing architecture defined
PACS and RIS integration approach validated
EHR integration using HL7 FHIR was designed and tested
Alert routing logic designed for the critical finding workflow
Clinician interface tested with real users from the target specialty

Compliance and Security

HIPAA compliance architecture documented
All DICOM data is encrypted in transit and at rest
Role-based access controls implemented
Audit logging is configured for all patient data access
Business Associate Agreements in place with all third-party services
FDA regulatory submission prepared if required

Deployment and Operations

Clinical pilot protocol defined with agreed success metrics
Post-deployment monitoring infrastructure in place
Model drift detection configured
Model update process aligned with the FDA's predetermined change control plan

How Codieshub Approaches AI Medical Imaging Software Development

At Codieshub, we build healthcare AI products for clinical environments, not controlled research settings. Every AI medical imaging engagement begins with our MVP and product strategy process, which explicitly addresses regulatory classification, HIPAA compliance architecture, and data strategy before a single line of production code is written. Our AI and ML solutions team then builds medical imaging models with explainability built in, confidence scoring, heatmap visualization, and uncertainty quantification because we have learned that a model with impressive benchmark performance will not be adopted if clinicians cannot understand its reasoning.

From there, our healthcare UI/UX design team designs radiologist and clinician interfaces tested with real users from the target specialty in conditions that approximate the actual clinical environment. Our healthcare software development team handles the complete clinical integration layer, DICOM processing, PACS and RIS integration, EHR integration using HL7 FHIR, alert routing, and audit logging entirely in-house without subcontractors. Integration is not a detail we address at the end. It is a design constraint we built around from the beginning.

After launch, our DevOps and cloud solutions team builds the post-deployment monitoring infrastructure that keeps the platform performing reliably as scanner technology, clinical protocols, and patient populations change, including model drift detection, performance monitoring dashboards, and model update pipelines as part of every production deployment we deliver. Get a Free Project Estimate. Tell us about your AI medical imaging project, and we will send you a tailored development and regulatory game plan within 48 hours.

Conclusion

AI medical imaging software development is one of the most technically demanding and clinically consequential areas of healthcare technology. The tools being built today are detecting cancers that would otherwise be missed, prioritizing strokes that need immediate intervention, and giving clinicians a level of analytical support that was simply not possible five years ago.

Building in this space requires more than machine learning expertise. It requires clinical domain understanding, regulatory navigation capability, HIPAA compliance architecture built from the ground up, and a clinical integration approach that fits into real workflows rather than around them.

At Codieshub, we bring all of these capabilities to AI medical imaging projects from the initial regulatory and compliance architecture through model development, clinical validation, and the long-term operational monitoring that keeps an AI imaging platform performing reliably in production. Get a Free Project Estimate. Tell us about your AI medical imaging project, and we will send you a tailored game plan within 48 hours.

Frequently Asked Questions

1. What is AI medical imaging software?

AI medical imaging software uses machine learning to analyze X-rays, CT scans, MRIs, and pathology slides. It helps clinicians detect findings, prioritize urgent cases, and improve diagnostic accuracy while supporting, not replacing, physician decision-making.

2. Does AI medical imaging software need FDA clearance?

Yes. Most AI medical imaging tools that make clinical claims require FDA clearance as Software as a Medical Device (SaMD). Approval pathways may include 510(k), De Novo, or PMA, depending on the software’s clinical risk level.

3. Does AI medical imaging software need to be HIPAA compliant?

Yes. AI medical imaging platforms must follow HIPAA regulations because medical images contain protected health information. Compliance includes encryption, role-based access control, audit logging, and secure data handling across all systems and third-party services.

4. How long does AI medical imaging software development take?

Developing a production-ready AI medical imaging platform usually takes 18 to 36 months. Timelines depend on dataset preparation, AI model development, clinical validation, regulatory approval, and integration with existing healthcare systems.

5. What data is needed to train an AI medical imaging model?

AI medical imaging models require large datasets of annotated clinical images reviewed by medical specialists. Data should include diverse patient demographics, scanner types, and imaging protocols to improve model accuracy and real-world clinical performance.

6. How much does AI medical imaging software development cost?

AI medical imaging software development typically costs between $300,000 and $800,000 or more. Major expenses include dataset collection, annotation, AI model training, compliance, clinical validation, and integration with healthcare infrastructure and imaging systems.

7. What is DICOM, and why does it matter for AI medical imaging?

DICOM is the global standard for storing and sharing medical imaging data. AI medical imaging software must support DICOM to integrate with scanners, PACS, RIS, and hospital systems used in clinical imaging workflows.

8. What is the difference between AI medical imaging software and a CDSS?

AI medical imaging software focuses on analyzing medical images, while a Clinical Decision Support System (CDSS) uses broader clinical data like lab results, medications, and patient history to support healthcare decision-making across multiple clinical areas.